Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02199-0
Abstract: There is limited data evaluating clinical outcomes of rivaroxaban versus warfarin in obese patients with venous thromboembolism (VTE). Our objective was to evaluate the effectiveness and safety of rivaroxaban versus warfarin in obese VTE patients.…
read more here.
Keywords:
vte;
rivaroxaban versus;
versus warfarin;
warfarin obese ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of the National Medical Association"
DOI: 10.1016/j.jnma.2020.04.014
Abstract: INTRODUCTION Black patients are under-represented in randomized trials evaluating oral anticoagulants in non-valvular atrial fibrillation (NVAF). We sought to evaluate the effectiveness and safety of rivaroxaban versus warfarin in African Americans with NVAF. METHODS We…
read more here.
Keywords:
atrial fibrillation;
rivaroxaban versus;
rivaroxaban;
american patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Thrombosis research"
DOI: 10.1016/j.thromres.2018.01.046
Abstract: INTRODUCTION Screening for primary hypercoagulable states (PHSs) in venous thromboembolism (VTE) patients was not mandated in the EINSTEIN trials; and therefore, few patients with a known PHS were available for analysis. We sought to assess…
read more here.
Keywords:
rivaroxaban versus;
effectiveness safety;
patients known;
rivaroxaban ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013465
Abstract: Objective: This article analyzed the clinical efficacy and tolerability of rivaroxaban and enoxaparin in patients undergoing total knee arthroplasty (TKA) surgery. Methods: Five randomized, controlled clinical trials on rivaroxaban versus enoxaparin in patients who underwent…
read more here.
Keywords:
rivaroxaban versus;
enoxaparin;
total knee;
dvt ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029620954910
Abstract: African Americans (AAs) and obese individuals have increased thrombotic risk. This study evaluated the effectiveness and safety of rivaroxaban versus warfarin in obese, AAs with nonvalvular atrial fibrillation (NVAF) or venous thromboembolism (VTE). OptumĀ® De-Identified…
read more here.
Keywords:
atrial fibrillation;
rivaroxaban versus;
rivaroxaban;
african americans ... See more keywords